Topf, A.; Paar, V.; Grueninger, J.; Wernly, B.; Kopp, K.; Weber, T.; Schernthaner, C.; Mirna, M.; Gharibeh, S.X.; Larbig, R.;
et al. sST2 Predicts Short Term Therapy Success in Patients with Therapy Resistant Hypertension after Renal Sympathetic Denervation. Appl. Sci. 2021, 11, 11130.
https://doi.org/10.3390/app112311130
AMA Style
Topf A, Paar V, Grueninger J, Wernly B, Kopp K, Weber T, Schernthaner C, Mirna M, Gharibeh SX, Larbig R,
et al. sST2 Predicts Short Term Therapy Success in Patients with Therapy Resistant Hypertension after Renal Sympathetic Denervation. Applied Sciences. 2021; 11(23):11130.
https://doi.org/10.3390/app112311130
Chicago/Turabian Style
Topf, Albert, Vera Paar, Janine Grueninger, Bernhard Wernly, Kristen Kopp, Thomas Weber, Christiana Schernthaner, Moritz Mirna, Sarah X. Gharibeh, Robert Larbig,
and et al. 2021. "sST2 Predicts Short Term Therapy Success in Patients with Therapy Resistant Hypertension after Renal Sympathetic Denervation" Applied Sciences 11, no. 23: 11130.
https://doi.org/10.3390/app112311130
APA Style
Topf, A., Paar, V., Grueninger, J., Wernly, B., Kopp, K., Weber, T., Schernthaner, C., Mirna, M., Gharibeh, S. X., Larbig, R., Pistulli, R., Hoppe, U. C., Lichtenauer, M., Motloch, L. J., & Brandt, M. C.
(2021). sST2 Predicts Short Term Therapy Success in Patients with Therapy Resistant Hypertension after Renal Sympathetic Denervation. Applied Sciences, 11(23), 11130.
https://doi.org/10.3390/app112311130
